Apricus Biosciences Updates Strategic Corporate Objectives
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Houthi attack on Saudi airport kills 12, over 300 wounded, authorities say
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Apricus Biosciences (APRI) Gains Early on Refocused Strategy
April 6, 2016 7:13 AM EDTApricus Biosciences (Nasdaq: APRI) shares are notably higher in early trading Wednesday after the company announced an update to its strategic objectives. The company said it plans to "prioritize Vitaros commercial and regulatory activities and to deprioritize all other pipeline programs."
Shares of Apricus are indicated over 17 percent higher.
... More


